- Price
- $8.86
- Day
- -1.34%
- Mkt Cap
- $709.75M
- 52W Range
- $7.00 – $14.87
- Volume
- 152.3K
- Beta
- 0.39
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in upcoming investor conferences.
Read full article